A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Study Identifier
191622-103
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
12 - 17 Years
Protocol Summary
To evaluate the efficacy and safety of Botulinum Toxin Type A versus placebo (normal saline) as headache prophylaxis in adolescents (children 12 to 17) with chronic migraine.
Study Locations
Location
Status
Location
Phoenix Children's Hospital
Phoenix, Arizona, United States, 85016
Status
Not applicable
Location
Fullerton Neurology and Headache Center
Fullerton, California, United States, 92835
Status
Not applicable
Location
The Research Center of Southern California
Oceanside, California, United States, 92056
Status
Not applicable
Location
San Francisco Clinical Research Center
San Francisco, California, United States, 94109
Status
Not applicable
Location
Stanford Hospital and Clinics
Stanford, California, United States, 94305
Status
Not applicable
Location
Associated Neurologists of Southern CT, P.C.
Fairfield, Connecticut, United States, 06824
Status
Not applicable
Showing {first} - {last} of {total} Results